Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 6,883 | 8,264 | 7,124 | 7,482 | 6,273 |
| Operating Income | -6,883 | -8,264 | -7,124 | -7,482 | -6,273 |
| Other Income | 513 | -478 | 360 | -49 | 282 |
| Pre-tax Income | -6,370 | -8,742 | -6,764 | -7,531 | -5,991 |
| Income Tax | -1 | 6 | 3 | N/A | N/A |
| Net Income Continuous | -6,369 | -8,748 | -6,767 | -7,532 | -5,991 |
| Minority Interests | 8 | 7 | 5 | 23 | 48 |
| Net Income | $-6,361 | $-8,741 | $-6,763 | $-7,509 | $-5,943 |
| EPS Basic Total Ops | -0.19 | -0.26 | -0.21 | -0.22 | -0.17 |
| EPS Basic Continuous Ops | -0.19 | -0.26 | -0.21 | -0.22 | -0.17 |
| EPS Diluted Total Ops | -0.19 | -0.26 | -0.21 | -0.22 | -0.17 |
| EPS Diluted Continuous Ops | -0.19 | -0.26 | -0.21 | -0.22 | -0.17 |
| EBITDA(a) | $-6,307 | $-8,687 | $-6,718 | $-7,476 | $-5,953 |